Dr. Jason Berilgen, MD
Radiation Oncology
Dr. Jason Berilgen is a board-certified radiation oncologist who treats prostate cancer and other urologic cancers for patients of Texas Regional Urology. When radiation is part of a patient's treatment plan, he is the physician who delivers it — working alongside our urologists so that surgical and radiation care are planned together rather than in isolation.
He graduated magna cum laude from Washington University in St. Louis with a bachelor's degree in physics, then earned his medical degree from Baylor College of Medicine in Houston, completing clinical rotations at Houston Methodist Hospital and MD Anderson Cancer Center. In 2003 he received the American Society of Hematology Medical Student Award.
Dr. Berilgen completed his residency in radiation oncology at the University of Texas Medical Branch in Galveston, where he served as chief resident. During training he pursued additional elective work at MD Anderson Cancer Center and completed pediatric radiation oncology training at St. Jude Children's Research Hospital in Memphis. He is board certified in radiation oncology by the American Board of Radiology.
His practice centers on precision — delivering radiation that conforms tightly to the tumor while sparing the healthy tissue around it. For prostate cancer in particular, that precision is what protects the bladder, the rectum, and the nerves that matter to a patient's quality of life afterward. He works across the full range of modern techniques, including image-guided and intensity-modulated radiotherapy, stereotactic radiotherapy, volumetric arc therapy, and high-dose-rate brachytherapy for prostate and other cancers.
Dr. Berilgen is head of radiation oncology and diagnostic imaging at Woodlands Cancer Institute, and serves as a medical director of radiation oncology for the American Oncology Network. He previously directed radiation oncology at Millennium Physicians and served as medical director and comprehensive cancer center director at Sadler Clinic.
He has been an investigator on clinical trials of new radiation and radiopharmaceutical treatments, including a national Phase III trial of radium-223 for metastatic castration-resistant prostate cancer.
Outside of work, he plays tennis, chess, and poker.
He graduated magna cum laude from Washington University in St. Louis with a bachelor's degree in physics, then earned his medical degree from Baylor College of Medicine in Houston, completing clinical rotations at Houston Methodist Hospital and MD Anderson Cancer Center. In 2003 he received the American Society of Hematology Medical Student Award.
Dr. Berilgen completed his residency in radiation oncology at the University of Texas Medical Branch in Galveston, where he served as chief resident. During training he pursued additional elective work at MD Anderson Cancer Center and completed pediatric radiation oncology training at St. Jude Children's Research Hospital in Memphis. He is board certified in radiation oncology by the American Board of Radiology.
His practice centers on precision — delivering radiation that conforms tightly to the tumor while sparing the healthy tissue around it. For prostate cancer in particular, that precision is what protects the bladder, the rectum, and the nerves that matter to a patient's quality of life afterward. He works across the full range of modern techniques, including image-guided and intensity-modulated radiotherapy, stereotactic radiotherapy, volumetric arc therapy, and high-dose-rate brachytherapy for prostate and other cancers.
Dr. Berilgen is head of radiation oncology and diagnostic imaging at Woodlands Cancer Institute, and serves as a medical director of radiation oncology for the American Oncology Network. He previously directed radiation oncology at Millennium Physicians and served as medical director and comprehensive cancer center director at Sadler Clinic.
He has been an investigator on clinical trials of new radiation and radiopharmaceutical treatments, including a national Phase III trial of radium-223 for metastatic castration-resistant prostate cancer.
Outside of work, he plays tennis, chess, and poker.
About Dr. Berilgen
Related Conditions
Prostate Cancer
The most common cancer among American men — and one where the right treatment depends as much on the specifics of your case as on the diagnosis itself.
Bladder Cancer
Caught early, bladder cancer is highly treatable. For some patients, radiation combined with chemotherapy offers a way to treat the cancer while preserving the bladder.
Testicular Cancer
Among the most curable cancers in medicine. Radiation plays a selective role in treating certain seminomas.
